WONOEP appraisal: Modeling early onset epilepsies
Abstract
Epilepsy has a peak incidence during the neonatal to early childhood period. These early onset epilepsies may be severe conditions frequently associated with comorbidities such as developmental deficits and intellectual disability and, in a significant percentage of patients, may be medication‐resistant. The use of adult rodent models in the exploration of mechanisms and treatments for early life epilepsies is challenging, as it ignores significant age‐specific developmental differences. More recently, models developed in immature animals, such as rodent pups, or in three‐dimensional organoids may more closely model aspects of the immature brain and could result in more translatable findings. Although models are not perfect, they may offer a more controlled screening platform in studies of mechanisms and treatments, which cannot be done in pediatric patient cohorts. On the other hand, more simplified models with higher throughput capacities are required to deal with the large number of epilepsy candidate genes and the need for new treatment options. Therefore, a combination of different modeling approaches will be beneficial in addressing the unmet needs of pediatric epilepsy patients. In this review, we summarize the discussions on this topic that occurred during the XVI Workshop on Neurobiology of Epilepsy, organized in 2022 by the Neurobiology Commission of the International League Against Epilepsy. We provide an overview of selected models of early onset epilepsies, discussing their advantages and disadvantages. Heterologous expression models provide initial functional insights, and zebrafish, rodent models, and brain organoids present increasingly complex platforms for modeling and validating epilepsy‐related phenomena. Together, these models offer valuable insights into early onset epilepsies and accelerate hypothesis generation and therapy discovery.Keywords
Funding Information
- Agence Nationale de la Recherche (S1800.ANR.MOSAIC)
- National Health and Medical Research Council (2019804)
- National Institute of Neurological Disorders and Stroke (U54 NS100064, RO1 NS043209, RO1 NS127524)
- U.S. Department of War (W81XWH‐22‐1‐0510, W81XWH‐22‐1‐0210)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50 HD105352)
- Science Foundation Ireland (16/RC/3948, 21/RC/10294_P2)
This publication has 80 references indexed in Scilit:
- A companion to the preclinical common data elements for rodent models of pediatric acquired epilepsy: A report of the TASK3‐WG1B, Pediatric and Genetic Models Working Group of the ILAE/AES Joint Translational Task ForceEpilepsia Open, 2022
- A companion to the preclinical common data elements for rodent genetic epilepsy models. A report of the TASK3‐WG1B: Paediatric and genetic models working group of the ILAE/AES joint translational TASK forceEpilepsia Open, 2022
- Recurrent seizure‐related GRIN1 variant: Molecular mechanism and targeted therapyAnnals of Clinical and Translational Neurology, 2021
- A companion to the preclinical common data elements on neurobehavioral comorbidities of epilepsy: a report of the TASK3 behavior working group of the ILAE/AES Joint Translational Task ForceEpilepsia Open, 2018
- Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure DrugsNeurochemical Research, 2017
- Quinidine in the treatment ofKCNT1‐positive epilepsiesAnnals of Neurology, 2015
- Does Epilepsy Cause a Reversion to Immature Function?2014
- KCNT1gain of function in 2 epilepsy phenotypes is reversed by quinidineAnnals of Neurology, 2014
- Novel Animal Models of Pediatric EpilepsyNeurotherapeutics, 2012
- Resistance of immature hippocampus to morphologic and physiologic alterations following status epilepticus or kindlingHippocampus, 2001